Showing results (241-250 of 667) with videos related to

Sort By:
Pageof 67
Hemasphere|August 8, 2022
Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical SettingTatjana Pandzic, Claes Ladenvall, Marie Engvall, et al.
Hemasphere|March 2, 2023
Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 TrialKatja Weisel, Meletios A Dimopoulos, Jesús San-Miguel, et al.
Hemasphere|February 6, 2023
Resource: A Cellular Developmental Taxonomy of the Bone Marrow Mesenchymal Stem Cell Population in MicePaola Pisterzi, Lanpeng Chen, Claire van Dijk, et al.
Hemasphere|November 18, 2022
Acalabrutinib Versus Investigator's Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial ResultsPaolo Ghia, Andrzej Pluta, Małgorzata Wach, et al.
Hemasphere|February 27, 2023
Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert PanelLivio Pagano, Pier Luigi Zinzani, Stefano Pileri, et al.
Hemasphere|February 18, 2026
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformationChiara Cosentino, Samir Mouhssine, Antonella Zucchetto, et al.
Hemasphere|March 11, 2025
Cell-free DNA for detection and monitoring of extramedullary AML relapseHenri C Hupe, Clara P Wienecke, Stephan Bartels, et al.
Hemasphere|February 14, 2025
HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantationSophie Le Grand, Juliette Villemonteix, Etienne Daguindau, et al.
Hemasphere|November 15, 2024
Preclinical evaluation of the CD38-targeting engineered toxin body MT-0169 against multiple myelomaWassilis S C Bruins, Rosa Rentenaar, John Newcomb, et al.
Hemasphere|November 13, 2024
Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter RegistryDavid F Moreno, Cristina Jiménez, Fernando Escalante, et al.
Pageof 67